| Secondary metabolites from marine sources | |||||
---|---|---|---|---|---|---|
SN | Secondary metabolites | Species | Structure | Applications | Pubchem ID | Reference |
 | Anticancer | |||||
1 | Aureoverticillactam | Streptomyces aureoverticillatus | Cytotoxicity of various cell types of tumors | 9868536 | [51] | |
2 | Caprolactones | Streptomyces sp. |
| Activity against cancer cell lines | 10401 | [52] |
3 | Chinikomycins | Streptomyces sp. | Antitumor action against different cancer cell lines in humans | 11273076 | [53] | |
4 | IB-00208 | Actinomadura sp. | Cytotoxic activity on tumor cell lines and bactericidal activity against Gram-positive bacteria | 139583280 | [54] | |
5 | Salinosporamide A (NPI-0052) | Salinisporatropica |
| Cytotoxicity, inhibition of the proteosome and inhibition of the activation of NF-κB | 11347535 | [55] |
6 | Urdamycin | Streptomyces fradiae | Contains biomolecules of aminoglycoside and strong antibacterial and anti-cancer activity | 443819 | [56] | |
7 | Himastatin | Streptomyces hygroscopicus | Includes valine, leucine, threonine, α-hydroxyisovaleric acid, 5-hydroxypiperazic acid, and a dimeric hexahydropyrroloindole. | 9855348 | [57] | |
8 | Daryamide D | Streptomyces strain CNQ-085 |
| Cytotoxic activity against cell line HCT-116 of human colon carcinoma and antifungal activity against Candida albicans | 132609319 | [58] |
9 | Marinomycin | Marinispora sp. strain CNQ-140 | Inhibition of cancer cell proliferation | Â | [59] | |
10 | Manumycin | Streptomyces sp. M045 | Antitumor activity against different human cancer cell lines | 6438330 | [53] | |
11 | Marmycin | Streptomyces sp. | Cytotoxicity of tumor cells tended to correlate with moderate apoptosis induction and arrest during the G1 cell cycle process | 91801297 | [60] | |
12 | Nonactin | Streptomyces tsukubaensis, Streptomyces griseus, Streptomyces chrysomallus, and Streptomyces werraensis. | Vigorous antineoplastic and antibacterial activity | 72519 | [61] | |
13 | Chartreusin | Streptomyces chartreusis |
| Active against certain gram-positive bacteria | 5281394 | [62] |
14 | Altemicidin | Streptomyces sioyaensis SA-1758. |
| Acaricidal activity and antitumor activity | 11036174 | [63] |
15 | Streptochlorin | Streptomyces sp. | Promising chemotherapeutic agent to the treatment of cholangiocarcinoma | 44608049 | [64] | |
16 | Marineosins | Streptomyces sp. |
| Significant inhibition of human colon carcinoma | 135960042 | [65] |
17 | Ammosamides | Streptomyces variabilis |
| Cytotoxicity to the MIA PaCa-2 pancreatic cancer cell line | 25113669 | [66] |
18 | Caboxamycin | Streptomyces sp. NTK 937 |
| Inhibitory activity against Gram-positive bacteria, selected human tumor cell lines and the enzyme phosphodiesterase | 135957253 | [67] |
19 | Hoiamide D | Symploca sp | screening inhibitory activity in contrast to 53/Mdm2 interaction | 56835050 | [68] | |
20 | Niphateolide | Niphates olemda |
| p53-Hdm2/Mdm2 interaction inhibitor | 132989992 | [69] |
21 | Hexylitaconic acid | Arthrinium sp |
| blocks p53/Mdm2 binding | 11447214 | [70] |
22 | Lissoclinidine B | Lissoclinum cf. badium |
| kills altered cells with wild-type p53 | 25147779 | [71] |
23 | Himeic acid A | Aspergillus sp. |
| Ubiquitin-Activating Enzyme (E1) inhibitory action | 11774903 | [72] |
24 | Girolline | Cymbastela cantharell and Axinella brevistyla |
| initiating G2/M cell cycle arrest in cancer cells | 362388 | [73] |
25 | Leucettamol A | Leucetta aff. microrhaphis | inhibits the ubiquitin E2 enzymes Ubc13 and Uev1A by 50% | 6271251 | [74] | |
26 | Dysidiolide | Dysidea etheria |
| capable of inhibiting Cdc25 protein phosphatase | 11269661 | [75] |
27 | Sulfircin | Ircinia sp |
| inhibit Cdc25 phosphatase | 44381469 | [76] |
28 | Coscinosulfate | Coscinoderma mathewsi |
| inhibitory activity towards Cdc25A | 102305354 | [77] |
29 | Halenaquinone | Xestospongia carbonaria |
| irreversible inhibitor of recombinant human Cdc25B phosphates | 370346 | [78] |
30 | Secalonic acid D | Penicillium oxalicum | slow the course of the cell cycle in human embryonic palatal mesenchymal cells | 73431 | [79] | |
31 | Stellettin B | Jaspis stellifera |
| decrease in Cdk and an increase in p27 expression | 5352082 | [80] |
 | Antibacterial | |||||
32 | Abyssomicins | Verrucosispora sp. |
| Inhibits the pathway between chorismate and para-aminobenzoic acid | 12094197 | [81] |
33 | Frigocyclinone | Streptomyces griseus |
| Lead molecule against Kaposi’s Sarcoma Associated Herpesvirus KSHV | 11476774 | [82] |
34 | Gutingimycin | Streptomyces sp. | Antibacterial antifungal and antimicroalgal activities | 136835719 | [83] | |
35 | Helquinoline | Janibacterlimosus |
| Antibacterial antifungal and antimicroalgal activities | 10466080 | [84] |
36 | Himalomycins | Streptomyces sp. |
| Antimicrobial activity against Gram-positive bacteria | 11765992 | [85] |
37 | Lajollamycin | Streptomyces nodosus | Antimicrobial activity against drug-sensitive and -resistant Gram-positive bacteria and inhibited the growth of B16-F10 tumor cells in vitro | 139587457 | [32] | |
38 | Tylosin | Streptomyces fradiae | Potential for the treatment of respiratory and other infections caused by Mycoplasma species |  | [86] | |
39 | Maklamicin | Micromonospora sp. GMKU326 |
| Antimicrobial activity against Gram-positive bacteria | 101796870 | [87] |
40 | Lobophorin K | Streptomyces sp. M-207 | Antibiotic activity against pathogenic Gram-positive bacteria | 139590476 | [88] | |
41 | Asenjonamide C | Streptomyces asenjonii strain KNN 42 |
| Antimicrobial activity against Gram-positive bacteria | 139589509 | [20] |
42 | Gilvocarcin HE | Streptomyces sp. | More significant cytotoxicity and antimicrobial activity due to the vinyl side chain | 102439806 | [21] | |
43 | Zunyimycins | Streptomyces sp. FJS31-2 | Inhibits the proliferation of lung cancer cells by the activation of apoptosis by an AKT pathway |  | [22] | |
44 | Formicamycins A | Streptomyces formicae | Potent antibacterial activity against clinical MRSA and VRE isolates |  | [23] | |
45 | Allocyclinones | Actinoallomurus | Possess activity against various Gram-positive bacteria, including antibiotic-resistant strains, with increasing antibacterial potency with the number of chlorine substitutes | Â | [24] | |
46 | Ageloline A | Streptomyces sp. SBT345 |
| Able to reduce oxidative stress and genomic damage induced by the oxidative stress inducer 4-nitroquinoline-1-oxide (NQO) | 1884 | [26] |
47 | Buanmycin | Streptomyces sp | Inhibition of sortase A, which is a promising target for antibiotic Discovery | Â | [89] | |
48 | Citreamicin | Streptomyces caelestis | Citreamicins exhibit cytotoxic activity against HeLa and Hep62 cells in addition to their potent antibiotic activity | 3083114 | [28] | |
49 | Kocurin | Kocuria sp. strain MI-67-EC3-038 | Kocurin is active against methicillin-resistant Staphylococcus aureus (MRSA) |  | [29] | |
50 | Fijimycins | Streptomyces sp. | Possess significant in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) strains |  | [86] | |
51 | Arylomycin | Streptomyces sp. HCCB10043 | Inhibits a promising antimicrobial target, type I signal peptidase (SPase) | Â | [90] | |
 | Antibacterial; anticancer | |||||
 | 1-Hydroxy-1-Norresistomycin | Streptomyces variabilis |
| Potent cytotoxic activity against cell lines viz. HMO2 (gastric adenocarcinoma) and HePG2 (hepatic carcinoma) in vitro |  | [91] |
 | Antibacterial; antifungal | |||||
52 | Bonactin | Streptomyces sp. | Bonactin displayed antimicrobial activity against both Gram-positive and Gram-negative bacteria as well as antifungal activity | 11741721 | Â | |
 | Anti-inflammatory | |||||
53 | Diazepinomicin (ECO-4601) | Micromonosproa sp. |
| Preclinical broad-spectrum antitumor potential, antioxidant and anti-protease activities. | 9868980 | [92] |
54 | Cyclomarins | Streptomyces sp. | Interesting lead structures for the development of drugs against tuberculosis and malaria | Â | [93] | |
 | Neurogenic activity | |||||
55 | Komodoquinone A | Streptomyces sp. KS3 |
| Induces differentiation of neuronal cells in the neuroblastoma cell line, Neuro 2A and arrests the cell cycle in step G1 | 11756746 | [94] |
56 | Granaticins | Streptomyces lateritius | Granaticinhas significant antitumor activity against P-388 lymphocytic leukemia in mice and cytotoxicity against KB cells. | Â | [95] | |
57 | Hymenialdisine | Agelasidae, Axinellidae, and Halichondriidae |
| suppresses many pro inflammatory cytokines (IL-1, IL-2, IL-6, and NO) by inhibition of NF-kB signaling pathway | 135413546 | [96] |
 | Antifungal | |||||
58 | Amphotericin B | Streptomyces nodosus | Treatment of most systemic fungal infections | 91819969 | Â | |
 | Anti tuberculosis | |||||
59 | Rifampicin | - | Rifampicin had immunomodulatory effects through its ability to modify human monocyte production of measured cytokines | Â | [97] | |
60 | Streptomycin | - | Antibiotic activity against gram-positive and gram- negative bacteria | 19649 | [97] | |
61 | Amikacin | - | Potent activity against Antibiotic-Resistant Clinical Isolates | 37768 | [97] | |
62 | Viomycin | - | Tuberculostatic agent active against both streptomycin – sensitive nad streptomycin – resistant strains | 135565959 | [97] | |
63 | Capreomycin | - | Bactericidal in vitro among the anti-TB drugs against non-replicating tubercle bacilli | 135565060 | [97] | |
64 | Kanamycin | - | Kanamycin intramuscular administration had a satisfactory effect in mice with staphylococci, pneumococci, and Ulebsiella pneumonia infections | 6032 | [97] | |
65 | Cycloserine | - | Antituberculous activity invitro and invivo | 6234 | [97] |